Target Audience

The Mount Sinai ADVANCED Heart Disease Symposium is a one-day intensive state-of-the-art review of heart failure and advanced cardiac care consisting of case reviews, didactic lectures, debates and expert panel discussions of emerging topics in heart failure, mechanical circulatory support and cardiac transplantation, showcasing the relevant clinical and research expertise at Mount Sinai Heart.

The 2017 Mount Sinai ADVANCED Heart Disease Symposium has been designed to meet the educational needs of General and Sub-Specialized Cardiologists, Cardiothoracic Surgeons, Nurses, Nurse Practitioners, Transplant Professionals, Fellows in Training, VAD Coordinators and Ancillary Staff committed to caring for complex cardiac patients. 

At the end of this CME activity participants should be able to:

  • Describe the worldwide burden of cardiovascular disease.
  • Recognize the clinical signs of congestion in heart failure patients.
  • Determine the new clinical practice guidelines for the use of valsartan/sacubatril and ivabradine.
  • Discuss the potential role of gene therapy for chronic systolic heart failure.
  • Assess the role of viruses in the development of cardiomyopathy.
  • Analyze the genetic basis for some forms of cardiomyopathy.
  • Recognize the potential for cancer chemotherapeutic agents to cause cardiomyopathy.
  • Assess the clinical signs of cardiac amyloidosis in susceptible individuals.
  • Describe current strategies to assess for myocardial recovery following LVAD implantation.
  • Describe the indications for catheter ablation of atrial fibrillation in heart failure patients.
  • Explain the outcomes with catheter ablation for ventricular tachycardia in ischemic cardiomyopathy.
  • Describe the role of percutaneous and surgical mitral valve repair for functional mitral regurgitation.
  • Determine the indicated uses for temporary support devices in cardiac resuscitation and decision-making.
  • Describe the major contributors to heart failure care disparities in minorities and women.
  • Discuss the role of nursing and multidisciplinary teams for comprehensive heart failure care delivery.
  • Describe the characteristics of patients with advanced heart failure (Stage D).
  • Recognize the triggers for referral for transplant and LVAD evaluation.
  • Explain the major clinical outcomes following heart transplant and LVAD implantation.


Symposium Overview